246 related articles for article (PubMed ID: 12181107)
1. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Am J Epidemiol; 2002 Aug; 156(4):363-73. PubMed ID: 12181107
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
4. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women.
Riman T; Dickman PW; Nilsson S; Nordlinder H; Magnusson CM; Persson IR
Eur J Epidemiol; 2004; 19(11):1011-9. PubMed ID: 15648594
[TBL] [Abstract][Full Text] [Related]
5. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.
Risch HA; Marrett LD; Jain M; Howe GR
Am J Epidemiol; 1996 Aug; 144(4):363-72. PubMed ID: 8712193
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for ovarian cancer: a case-control study.
Booth M; Beral V; Smith P
Br J Cancer; 1989 Oct; 60(4):592-8. PubMed ID: 2679848
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
9. Predictors of ovarian cancer survival: a population-based prospective study in Sweden.
Yang L; Klint A; Lambe M; Bellocco R; Riman T; Bergfeldt K; Persson I; Weiderpass E
Int J Cancer; 2008 Aug; 123(3):672-9. PubMed ID: 18498135
[TBL] [Abstract][Full Text] [Related]
10. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
Mills PK; Riordan DG; Cress RD; Goldsmith DF
Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372
[TBL] [Abstract][Full Text] [Related]
12. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
Riman T; Nilsson S; Persson IR
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
[TBL] [Abstract][Full Text] [Related]
13. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
[TBL] [Abstract][Full Text] [Related]
14. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.
Bešević J; Gunter MJ; Fortner RT; Tsilidis KK; Weiderpass E; Onland-Moret NC; Dossus L; Tjønneland A; Hansen L; Overvad K; Mesrine S; Baglietto L; Clavel-Chapelon F; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Agnoli C; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Jareid M; Quirós JR; Duell EJ; Sánchez MJ; Larrañaga N; Chirlaque MD; Barricarte A; Dias JA; Sonestedt E; Idahl A; Lundin E; Wareham NJ; Khaw KT; Travis RC; Rinaldi S; Romieu I; Riboli E; Merritt MA
Br J Cancer; 2015 Dec; 113(11):1622-31. PubMed ID: 26554655
[TBL] [Abstract][Full Text] [Related]
15. The risk of epithelial ovarian cancer in short-term users of oral contraceptives.
Gross TP; Schlesselman JJ; Stadel BV; Yu W; Lee NC
Am J Epidemiol; 1992 Jul; 136(1):46-53. PubMed ID: 1415131
[TBL] [Abstract][Full Text] [Related]
16. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
[TBL] [Abstract][Full Text] [Related]
17. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness.
Modugno F; Ness RB; Wheeler JE
Ann Epidemiol; 2001 Nov; 11(8):568-74. PubMed ID: 11709277
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study.
Hempling RE; Wong C; Piver MS; Natarajan N; Mettlin CJ
Obstet Gynecol; 1997 Jun; 89(6):1012-6. PubMed ID: 9170483
[TBL] [Abstract][Full Text] [Related]
19. Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies.
Negri E; Tzonou A; Beral V; Lagiou P; Trichopoulos D; Parazzini F; Franceschi S; Booth M; La Vecchia C
Int J Cancer; 1999 Mar; 80(6):848-51. PubMed ID: 10074916
[TBL] [Abstract][Full Text] [Related]
20. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.
Fu Z; Brooks MM; Irvin S; Jordan S; Aben KKH; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Brooks-Wilson A; Chang-Claude J; Cook LS; Cramer DW; Cushing-Haugen KL; Doherty JA; Ekici AB; Fasching PA; Fortner RT; Gayther SA; Gentry-Maharaj A; Giles GG; Goode EL; Goodman MT; Harris HR; Hein A; Kaaks R; Kiemeney LA; Köbel M; Kotsopoulos J; Le ND; Lee AW; Matsuo K; McGuire V; McLaughlin JR; Menon U; Milne RL; Moysich KB; Pearce CL; Pike MC; Qin B; Ramus SJ; Riggan MJ; Rothstein JH; Schildkraut JM; Sieh W; Sutphen R; Terry KL; Thompson PJ; Titus L; van Altena AM; White E; Whittemore AS; Wu AH; Zheng W; Ziogas A; Taylor SE; Tang L; Songer T; Wentzensen N; Webb PM; ; Risch HA; Modugno F
J Natl Cancer Inst; 2023 May; 115(5):539-551. PubMed ID: 36688720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
